Company intelligence
Ionic
Cytometry Made Easy!
About Ionic
We do not see ourselves as traditional consultants but rather as counterparts with complementary expertise. We provide each client with a personalized, custom cytometry investigation based on two-way discourse, enhancing the robustness of the science conducted and bridging the gap between analysis and insight. We begin the process by meeting with clients to understand their project and research goals. If the client has not yet collected data, we build a panel based on the relevant biomarkers, design experiments and protocols to qualify the panel, and advise on appropriate data collection techniques. If the client has already collected data, we will develop an analysis strategy to achieve their goals. Once data becomes available, our custom data analysis reveals its most compelling insights. We meet one-on-one with clients to discuss analyses and assist them in interpreting results and their implications. Our team provides strategies for applying insights to future studies, grant applications, manuscripts, and presentations at scientific and medical conferences.
Verified activity
Signals from Ionic
3 published signals
Presence & Recognition
Ionic featured Christian Aguilera-Sandoval and Eric Haas in their latest episode of Go With the Flow, A Cytometry Podcast discussing Pratip Chattopadhyay and the future of cytometry.
Reported by Eric Haas
Legal & Regulatory
Ionic reported that several autoimmune CAR T cell trials from Novartis and Bristol Myers Squibb were halted due to adverse inflammatory immune related events, including several patient deaths.
Reported by Eric Haas
Research & Knowledge
Ionic published a paper published with City of Hope analyzing differences between CAR T cells in R/R vs. CR1 patients using a 48-parameter CyTOF panel.
Reported by Eric Haas